Obesity - A disease with many aetiologies disguised in the same oversized phenotype: Has the overeating theory failed?

Nephrology Dialysis Transplantation

Volumn 30, Issue 10, 2015, Pages 1656-1664

  Stenvinkel, Peter ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

epigenome; gut microbiota; insulin resistance; mitochondria; obesity

Indexed keywords

FRUCTOSE; GLUCOSE; TRANSCRIPTION FACTOR NRF2; TRIACYLGLYCEROL;

BACTEROIDETES; BODY MASS; CALORIC INTAKE; CAUSAL ATTRIBUTION; CHRONIC KIDNEY DISEASE; DYSLIPIDEMIA; ENERGY METABOLISM; EPIDEMIC; EPIGENETICS; FAT MASS; FIRMICUTES; FISH; GENETIC PREDISPOSITION; HUMAN; HYPERINSULINEMIA; HYPERURICEMIA; INSULIN RESISTANCE; INTESTINE FLORA; LIPID DIET; LIPID STORAGE; MITOCHONDRION; NEUROTRANSMISSION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUT; OBESITY; OVERNUTRITION; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SOFT DRINK; SUGAR INTAKE; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; VACCINIUM; VIRUS INFECTION; ADVERSE EFFECTS; DIET; HYPERPHAGIA; METABOLIC SYNDROME X; METABOLISM; PATHOPHYSIOLOGY; PHENOTYPE;

DIET; HUMANS; HYPERPHAGIA; METABOLIC SYNDROME X; MITOCHONDRIA; OBESITY; PHENOTYPE;

EID: 84943428908     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfu338     Document Type: Review

References (100)

1. Stenvinkel P, Zoccali C, Ikizler TA. Obesity in CKD-what should nephrologists know?. J Am Soc Nephrol 2013; 24: 1727-1736
2. Ng M, Fleming T, RobinsonMet al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014; 384: 766-781
3. Lustig RH, Schmidt LA, Brindis CD. The toxic truth about sugar. Nature 2012; 482: 27-29
4. Dali-Youcef N, Mecili M, Ricci R, et al. Metabolic inflammation: connecting obesity and insulin resistance. Ann Med 2013; 45: 242-253
5. Odegaard JI, Chawla A. Pleiotropic actions of insulin resistance and inflammation in metabolic homeostasis. Science 2013; 339: 172-177
6. Johnson RJ, Sanchez-Lozada LG, Nakagawa T. The effect of fructose on renal biology and disease. J Am Soc Nephrol 2012; 21: 2036-2039
7. Kramer H. Dietary patterns, calories, and kidney disease. Adv Chronic Kidney Dis 2013; 20: 135-140
8. Taube G. Treat obesity as physiology, not physics. Nature 2012; 492: 155
9. Alhéritière A, Montois S, Galinski M, et al. Worldwide relation between the number of McDonald's restaurants and the prevalence of obesity. J Intern Med 2013; 274: 610-611
10. Knight JA. Physical inactivity: associated diseases and disorders. Ann Clin Lab Sci 2012; 42: 320-337
11. Frank GK, Reynolds JR, Shott ME, et al. Anorexia nervosa and obesity are associated with opposite brain reward response. Neuropsychopharmacology 2012; 37: 2031-2046
12. Drummond EM, Gibney ER. Epigenetic regulation of obesity. Curr Opin Clin Nutr Metab Care. 2013; 16: 392-397
13. Ley RE, Turnbaugh PJ, Klein S, et al. Microbial ecology: human gut microbes associated with obesity. Nature 2006; 444: 1022-1023
14. Atkinson RL. Could viruses contribute to the worldwide epidemic of obesity?. Int J Pediatr Obes 2008; 3: 37-43
15. Roncal-Jimenez CA, Lanaspa MA, Rivard CJ, et al. Sucrose induces fatty liver and pancreatic inflammation in male breeder rats independent of excess energy intake. Metabolism 2011; 60: 1259-1270
16. Lanaspa MA, Ishimoto T, Li N, et al. Endogenous fructose production and metabolism in the liver contributes to the development of metabolic syndrome. Nat Commun 2013; 4: 2434
17. Crawford D, Jeffery RW, French SA. Can anyone successfully control their weight?. Findings of a three year community-based study of men and women. Int J Obes Relat Metab Disord 2000; 24: 1107-1110
18. Basu S, Yoffe P, Hills N, et al. The relationship of sugar to populationlevel diabetes prevalence: an econometric analysis of repeated cross-sectional data. PLoS ONE 2013; 8: e57973
19. Trirogoff ML, Shintani A, Himmelfarb J, et al. Body mass index and fat mass are the primary correlates of insulin resistance in nondiabetic stage 3-4 chronic kidney disease patients. Am J Clin Nutr 2007; 86: 1642-1648
20. Jia T, Huang X, Qureshi AR, et al. Validation of insulin sensitivity surrogate indices and prediction of clinical outcomes in individuals with and without impaired renal function. Kidney Int 2014; 86: 383-391
21. Blüher M. Are there still healthy obese patients?. Curr Opin Endocrinol Diabetes 2012; 19: 341-346
22. Samocha-Bonet D, Chisholm DJ, Tonks K, et al. Insulin-sensitive obesity in humans-a "favorable fat' phenotype?. Trends Endocrinol Metab 2012; 23: 116-124
23. Manolopoulos KN, Karpe F, Frayn KN. Gluteofemoral body fat as a determinat of metabolic health. Int J Obes (Lond) 2010; 34: 949-959
24. Voulgari C, Tentolouris N, Dilaveris P, et al. Increased heart failure risk in normal-weight people with metabolic syndrome compared with metabolically healthy obese individuals. J Am Coll Cardiol 2011; 58: 1343-1350
25. Asterholm IW, Mundy DI, Weng J, et al. Altered mitochondrial function and metabolic inflexibility associated with loss of caveolin-1. Cell Metab 2012; 15: 171-185
26. Johnson RJ, Stenvinkel P, Martin SL, et al. Redefining metabolic syndrome as a fat storage condition based on studies of comparative physiology. Obesity 2013; 21: 659-664
27. Stenvinkel P, Jani AH, Johnson RJ. Hibernating bears (Ursidae): metabolic magicians of definite interest for the nephrologist. Kidney Int 2013; 83: 207-212
28. Stenvinkel P, Fröbert O, Anderstam B, et al. Metabolic changes in summer active and anuric hibernating free-ranging brown bears (Ursus arctos) PLoS ONE 2013; 8: e72934
29. Arinell K, Sahdo B, Evans AL, et al. Brown bears (Ursus arctos) seem resistant to atherosclerosis despite highly elevated plasma lipids during hibernation and active state. Clin Transl Sci 2012; 5: 269-272
30. Nelson OL, Jansen HT, Galbreath E, et al. Grizzly bears exhibit augmented insulin sensitivity while obese prior to a reversible insulin resistance during hibernation. Cell Metab 2014; 20: 376-382
31. Le Tellier A. Blame Nixon for the obesity epidemic. Los Angeles Times 2012
32. Vos MB, Kimmons JE, Gillespie C, et al. Dietary fructose consumption among US children and adults: the Third National Health and Nutrition Examination Survey. Medscape J Med 2008; 9: 160
33. Consumption of food 1960-2006. Sweden: Statistik från jordbruksverket. 2009
34. Johnson RJ, Perez-Pozo SE, Sautin YY, et al. Hypothesis: could excessive fructose intake and uric acid cause type 2 diabetes?. Endocr Rev 2009; 30: 96-116
35. Stanhope KL, Schwarz JM, Havel P. Adverse metabolic effects of dietary fructose: results from the recent epidemiological, clinical and mechanistic studies. Curr Opin Lipidol 2013; 24: 198-206
36. Nakagawa T, Hu H, Zharikov S, et al. A causal role for uric acid in fructose-induced metabolic syndrome. Am J Physiol Renal Physiol 2006; 290: F625-F631
37. Stanhope KL, Schwarz JM, Keim NL, et al. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest 2009; 119: 1322-1334
38. Lustig RH. Fructose: it s alcohol without the buzz. Adv Nutr 2013; 4: 226-235
39. Friedman MI, Harris RB, Ramirez I, et al. Fatty acid oxidation affects food intake by altering hepatic energy status. Am J Physiol 1999; 276: R1046-R1053
40. Shapiro A, Mu W, Roncal C, et al. Fructose-induced leptin resistance exacerbates weight gain in response to subsequent high-fat feeding. Am J Physiol Regul Integr Comp Physiol 2008; 295: R1370-R1375
41. Lane MD, Cha SH. Effect of glucose and fructose on food intake via malonyl-CoA signaling in the brain. Biochem Biophys Res Commun 2009; 382: 1-5
42. Cox CL, Stanhope KL, Schwarz JM, et al. Consumption of fructose-sweetened beverages for 10 weeks reduces net fat oxidation and energy expenditure in overweight/obese men and women. Eur J Clin Nutr 2012; 66: 201-208
43. Yang Q, Zhang Z, Gregg EW, et al. Added sugar intake and cardiovascular diseases mortality among US adults. JAMA Intern Med 2014; 174: 516-524
44. Willett W, Manson J, Liu S. Glycemic index, glycemic load, and risk of type 2 diabetes. Am J Clin Nutr 2002; 76: 274S-280S
45. Newby PK, Tucker KL, Wolk A. Risk of overweight and obesity among semivegetarian, lactovegetarian, and vegan women. Am J Clin Nutr 2005; 81: 1267-1274
46. Johnson RJ, Nakagawa T, Sanchez-Lozada LG, et al. Sugar, uric acid, and the etiology of diabetes and obesity. Diabetes 2013; 62: 3307-3315
47. Lanaspa MA, Sanchez-Lozada LG, Choi YJ, et al. Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress: potential role in fructose-dependent and -independent fatty liver. J Biol Chem 2012; 287: 40732-40744
48. Feig DI, Soletsky B, Johnson RJ. Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial. JAMA 2008; 300: 924-932
49. Ghadirian P, Shatenstein B, Verdy M, et al. The influence of dairy products on plasma uric acid in women. Eur J Epidemiol 1995; 11: 275-281
50. Neel JV. Diabetes Mellitus: a thrifty genotype rendered detrimental by progress?. Am J Hum Genet 1962; 14: 353-362
51. Johnson RJ, Andrews P, Benner SA, et al. Theodore E. Woodward award. The evolution of obesity: insights from the mid-Miocene. Trans Am Clin Climatol Assos 2010; 121: 295-305
52. Nisoli E, Clementi E, Carruba MO, et al. Defective mitochondrial biogenesis: a hallmark of the high cardiovascular risk in the metabolic syndrome?. Circ Res 2007; 100: 795-806
53. Fleischman A, Kron M, Systrom DM, et al. Mitochondrial function and insulin resistance in overweight and normal-weight children. J Clin Endocrinol Metab 2009; 94: 4923-4930
54. Morino K, Petersen KF, Dufour S, et al. Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents. J Clin Invest 2005; 115: 3587-3593
55. Siriwardhana N, Kalupahana NS, Cekanova M, et al. Modulation of adipose tissue inflammation by bioactive food compounds. J Nutr Biochem 2013; 24: 613-623
56. Wang S, Moustaid-Moussa N, Chen L, et al. Novel insights of dietary polyphenols and obesity. J Nutr Biochem 2014; 25: 1-18
57. Timmers S, Hesselink MK, Schrauwen P. Therapeutic potential of resveratrol in obesity and type 2 diabetes: new avenues for health benefits?. Ann NY Acad Sci 2012; 1290: 83-89
58. Jimenez-Gomez Y, Mattison JA, Pearson KJ, et al. Resveratrol improves adipose insulin signaling and reduces the inflammatory response in adipose tissue of rhesus monkeys on high-fat, high-sugar diet. Cell Metab 2013; 18: 533-545
59. Schrauwen P, Timmers S. Can resveratrol help to maintain metabolic health?. Proc Nutr Soc 2014; 14: 1-7
60. Linderborg KM, Järvinen R, Lehtonen HM, et al. The fiber and/or polyphenols present in lingonberries null the glycemic effect of the sugars present in the berries when consumed together with added glucose in healthy human volunteers. Nutr Res 2012; 32: 471-478
61. Heyman L, Axling U, Blanco N, et al. Evaluation of beneficial metabolic effects of berries in high-fat fed C57BL/6J mice. J Nutr Metab 2014; 2014: 403041
62. Moghe SS, Juma S, Imrhan V, et al. Effect of blueberry polyphenols on 3T3-F442A preadipocyte differentiation. J Med Food 2012; 15: 448-452
63. Törrönen R, Kolehmainen M, Sarkkinen E, et al. Postprandial glucose, insulin, and free fatty acid responses to sucrose consumed with blackcurrants and lingonberries in healthy women. Am J Clin Nutr 2012; 96: 527-533
64. Kolehmainen M, Mykkänen O, Kirjavainen PV, et al. Bilberries reduce low-grade inflammation in individuals with features of metabolic syndrome. Mol Nutr Food Res 2012; 56: 1501-1510
65. Flores-Mateo G, Rojas-Rueda D, Basora J, et al. Nut intake and adiposity: meta-analysis of clinical trials. Am J Clin Nutr 2013; 97: 1346-1355
66. Gulati S, Misra A, Pandey RM, et al. Effects of pistachio nuts on body composition, metabolic, inflammatory and oxidative stress parameters in Asian Indians with metabolic syndrome: a 24-wk, randomized control trial. Nutrition 2014; 30: 192-197
67. Berryman CE, Grieger JA, West SG, et al. Acute consumption of walnuts and walnut components differentially affect postprandial lipemia, endothelial function, oxidative stress, and cholesterol efflux in humans with mild hypercholesterolemia. J Nutr 2013; 143: 788-794
68. Jaceldo-Siegl K, Haddad E, Oda K, et al. Tree nuts are inversely associated with metabolic syndrome and obesity: the adventist health study-2. PLoS ONE 2014; 9: e85133
69. Soory M. Nutritional antioxidants and their applications in cardiometabolic diseases. Infect Disord Drug Targets 2012; 12: 388-401
70. Schneider KS, Chan JY. Emerging role of Nrf2 in adipocytes and adipose biology. Adv Nutr 2013; 4: 62-66
71. Shin S, Wakabayashi J, Yates MS, et al. Role of Nrf2 in prevention of high-fat diet-induced obesity by synthetic triterpenoid CDDO-Imidazolide. Eur J Pharmacol 2009; 620: 138-144
72. de Zeeuw D, Akizawa T, Audhya P, et al. Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease. N Engl J Med 2013; 369: 2492-2503
73. Cardozo LF, Pedruzzi LM, Stenvinkel P, et al. Nutritional strategies to modulate inflammation and oxidative stress pathways via activation of the master antioxidant switch Nrf2. Biochimie 2013; 95: 1525-1533
74. Greenberg JA, Boozer CN, Geliebter A. Coffee, diabetes, and weight control. Am J Clin Nutr 2006; 84: 682-693
75. Spencer EA, Appleby PN, Davey GK, et al. Diet and body mass index in 38000 EPIC-Oxford meat-eaters, fish-eaters, vegetarians and vegans. Int J Obes Relat Metab Disord 2003; 27: 728-734
76. Gray B, Steyn F, Davies PS, et al. Omega-3 fatty acids: a review of the effects on adiponectin and leptin and potential implications for obesity management. Eur J Clin Nutr 2013; 67: 1234-1242
77. Horakova O, Medrikova D, van Schothorst EM, et al. Preservation of metabolic flexibility in skeletal muscle by a combined use of n-3 PUFA and rosiglitazone in dietary obese mice. PLoS ONE 2012; 7: e43764
78. Schwenk RW, Vogel H, Schürmann A. Genetic and epigenetic control of metabolic health. Mol Met 2013; 2: 337-347
79. Witasp A, Ekström T, Schalling M, et al. How can genetics and epigenetics help the nephrologist improve the diagnosis and treatment of chronic kidney disease patients?. Nephrol Dial Transplant 2014; 29: 972-980
80. Wang X, Zhu H, Snieder H, et al. Obesity related methylation changes in DNA of peripheral blood leukocytes. BMC Med 2010; 8: 87
81. Heijmans BT, Tobi EW, Stein AD, et al. Persistent epigenetic differences associated with prenatal exposure to famine in humans. Proc Natl Acad Sci USA 2008; 105: 17046-17049
82. Waterland RA, Jirtle RL. Transposable elements: targets for early nutritional effects on epigenetic gene regulation. Mol Cell Biol 2003; 23: 5293-5300
83. Dolinoy DC, Weidman JR, Waterland RA, et al. Maternal genistein alters coat color and protects Avy mouse offspring from obesity by modifying the fetal epigenome. Environ Health Perspect 2006; 114: 567-572
84. Widiker S, Karst S, Wagener A, et al. High-fat diet leads to a decreased methylation of the Mc4r gene in the obese BFMI and the lean B6 mouse lines. J Appl Genet 2010; 51: 193-197
85. Barrès R, Yan J, Egan B, et al. Acute exercise remodels promoter methylation in human skeletal muscle. Cell Metab 2012; 15: 405-411
86. Guénard F, Deshaies Y, Cianflone K, et al. Differential methylation in glucoregulatory genes of offspring born before vs. after maternal gastrointestinal bypass surgery. Proc Natl Acad Sci USA 2013; 110: 11439-11444
87. Turnbaugh PJ, Ridaura VK, Faith JJ, et al. The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci Transl Med 2009; 1: 6ra14
88. Ridaura V, Faith J, Rey F, et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science 2013; 341: 1241214
89. Schwiertz A, Taras D, Schäfer K, et al. Microbiota and SCFA in lean and overweight healthy subjects. Obesity (Silver Spring) 2010; 18: 190-195
90. Lin HV, Frassetto A, Kowalik EJ, et al. Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms. PLoS ONE 2012; 7: e35240
91. Remely M, Aumueller E, Merold C, et al. Effects of short chain fatty acid producing bacteria on epigenetic regulation of FFAR3 in type 2 diabetes and obesity. Gene 2014; 537: 85-92
92. Delzenne NM, Neyrinck AM, Cani PD. Modulation of the gut microbiota by nutrients with prebiotic properties: consequences for host health in the context of obesity and metabolic syndrome. Microb Cell Fact 2011; 10: S10
93. Wang Z, Klipfell E, Bennett BJ, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 2011; 472: 57-63
94. Koeth RA, Wang Z, Levison BS, et al. Intestinal microbiota metabolism of l-carnitin, a nutrient in red meat, promotes atherosclerosis. Nature Med 2013; 19: 576-585
95. Angelakis E, Merhej V, Raoult D. Related actions of probiotics and antibiotics on gut microbiota and weight modification. Lancet Infect Dis 2013; 13: 889-899
96. Trasande L, Blustein J, Liu M, et al. Infant antibiotic exposures and earlylife body mass. Int J Obesity 2013; 37: 16-23
97. Suez J, Korem T, Zeevi D, et al. Artificial sweeteners induce glucose intolerance by altering the gut microbiota. Nature 2014; 514: 181-186
98. Atkinson RL, Dhurandhar NV, Allison DB, et al. Human adenovirus-36 is associated with increased body weight and paradoxical reduction of serum lipids. Int J Obes (Lond) 2005; 29: 281-286
99. Ludwig DS, Friedman MI. Increasing adiposity. Consequence or cause of overeating?. JAMA 2014; 311: 2167-2168
100. Pan D, Mao C, Quattrochi B, et al. MicroRNA-378 controls classical brown fat expansion to counteract obesity. Nat Commun 2014; 22: 4725